(Q37685264)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

title

Evaluating oversight of human drugs and medical devices: a case study of the FDA and implications for nanobiotechnology (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

author name string

Jordan Paradise

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Alison W Tisdale

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Ralph F Hall

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 January 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

Journal of Law, Medicine, and Ethics

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

volume

37

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

598-624

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

An integrated approach to oversight assessment for emerging technologies

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

Developing U.S. oversight strategies for nanobiotechnology: learning from past oversight experiences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

The safety assessment process--setting the scene: an FDA perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

Nanotechnology: convergence with modern biology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

The emerging nanomedicine landscape

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

Risk assessment in the policy-making process: environmental health and safety protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

FDA: evidentiary standards for drug development and approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

How to avoid another 'Vioxx'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

The law. Vioxx verdict: too little or too much science?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

Lessons from the failure and recall of an implantable cardioverter-defibrillator.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

The controversy over Guidant's implantable defibrillators.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

Policy developments in regulatory approval

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

Medical device regulation: an introduction for the practicing physician

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

Medicine. Moving toward transparency of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

User-fee bill passes US Senate, but legislative hurdles remain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1748-720X.2009.00434.X

10.1111/J.1748-720X.2009.00434.X

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20122103%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference